A mindfulness-based intervention for breast cancer patients with cognitive impairment after chemotherapy: study protocol of a three-group randomized controlled trial

Katleen Van der Gucht, Michelle Melis, Soumaya Ahmadoun, Anneleen Gebruers, Ann Smeets, Mathieu Vandenbulcke, Hans Wildiers, Patrick Neven, Peter Kuppens, Filip Raes, Stefan Sunaert, Sabine Deprez, Katleen Van der Gucht, Michelle Melis, Soumaya Ahmadoun, Anneleen Gebruers, Ann Smeets, Mathieu Vandenbulcke, Hans Wildiers, Patrick Neven, Peter Kuppens, Filip Raes, Stefan Sunaert, Sabine Deprez

Abstract

Background: Mindfulness has been applied to improve cancer care by enhancing psychological well-being. However, little is known about its impact on cognitive impairment experienced by cancer patients after chemotherapy. Mindfulness may be relevant in tackling cognitive impairment by decreasing emotional distress and fatigue, by decreasing inflammation, and by strengthening functional brain connectivity. The aim of the present study protocol is to evaluate the efficacy and mechanisms of a mindfulness-based intervention to reduce cognitive impairment in breast cancer patients after chemotherapy.

Methods/design: The present study is a three-arm, parallel-group, randomized controlled trial with assessments at baseline, 1 to 3 weeks after the intervention and at 3 months' follow-up. One hundred and twenty breast cancer patients who ended treatment a minimum of 6 months and a maximum of 5 years before, and who have cognitive complaints, will be enrolled. They will be randomized into one of the following three study arms: (1) a mindfulness-based intervention group (n = 40), (2) an active control condition based on physical training (n = 40), or (3) a treatment as usual (TAU) control group (n = 40). Both the mindfulness-based intervention and the active control condition consist of four group sessions (3 h for the mindfulness condition and 2 h for the physical training) spread over 8 weeks. The primary outcomes will be cognitive symptoms as measured by the Cognitive Failure Questionnaire and changes in functional brain connectivity in the attention network. Secondary outcomes will be (1) levels of emotional distress, fatigue, mindfulness, quality of life; (2) neurocognitive tests; (3) structural and functional brain changes using MR imaging and (4) measures of inflammation.

Discussion: The study will examine the impact of a mindfulness-based intervention on cognitive impairment in breast cancer patients. If the findings of this study confirm the effectiveness of a mindfulness-based program to reduce cognitive impairment, it will be possible to improve quality of life for ex-cancer patients. We will inform health care providers about the potential use of a mindfulness-based intervention as a non-pharmaceutical, low-threshold mental health intervention to improve cognitive impairment after cancer.

Trial registration: ClinicalTrials.gov, ID: NCT03736460. Retrospectively registered on 8 November 2018.

Keywords: Brain imaging; Breast cancer; Cognitive impairment; Mindfulness; Randomized controlled trial.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Diagram of planned study flow
Fig. 2
Fig. 2
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) schedule. *A detailed description of the assessments measures is given in Table 2

References

    1. Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol. 2010;28(29):4434. doi: 10.1200/JCO.2009.27.0827.
    1. Wefel JS, Kesler SR, Noll KR, Schagen SB. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin. 2015;65(2):123–138. doi: 10.3322/caac.21258.
    1. Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012;12(3):267–275. doi: 10.1007/s11910-012-0264-9.
    1. Ahles TA, Root JC, Ryan EL. Cancer-and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol. 2012;30(30):3675. doi: 10.1200/JCO.2012.43.0116.
    1. Koppelmans V, Breteler M, Boogerd W, Seynaeve C, Gundy C, Schagen S. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol. 2012;30(10):1080–1086. doi: 10.1200/JCO.2011.37.0189.
    1. Stouten-Kemperman MM, de Ruiter MB, Caan MW, Boogerd W, Kerst MJ, Reneman L, et al. Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy. Hum Brain Mapp. 2015;36(11):4638–4647. doi: 10.1002/hbm.22942.
    1. Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer. 2007;7(3):192. doi: 10.1038/nrc2073.
    1. Marin M-F, Lord C, Andrews J, Juster R-P, Sindi S, Arsenault-Lapierre G, et al. Chronic stress, cognitive functioning and mental health. Neurobiol Learn Mem. 2011;96(4):583–595. doi: 10.1016/j.nlm.2011.02.016.
    1. Deprez S, Amant F, Smeets A, Peeters R, Leemans A, Van Hecke W, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol. 2011;30(3):274–281. doi: 10.1200/JCO.2011.36.8571.
    1. Deprez S, Amant F, Yigit R, Porke K, Verhoeven J, den Stock V, et al. Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp. 2011;32(3):480–493. doi: 10.1002/hbm.21033.
    1. Deprez S, Vandenbulcke M, Peeters R, Emsell L, Smeets A, Christiaens MR, et al. Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints. J Clin Oncol. 2014;32(19):2031–2U72. doi: 10.1200/JCO.2013.53.6219.
    1. Kesler SR. Default mode network as a potential biomarker of chemotherapy-related brain injury. Neurobiol Aging. 2014;35:S11–SS9. doi: 10.1016/j.neurobiolaging.2014.03.036.
    1. Chan RJ, McCarthy AL, Devenish J, Sullivan KA, Chan A. Systematic review of pharmacologic and non-pharmacologic interventions to manage cognitive alterations after chemotherapy for breast cancer. Eur J Cancer. 2015;51(4):437–450. doi: 10.1016/j.ejca.2014.12.017.
    1. Treanor CJ, McMenamin UC, O’Neill RF, Cardwell CR, Clarke MJ, Cantwell M, Donnelly M. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment. Cochrane Database Syst Rev. 2016;8:Cd011325. 10.1002/14651858.CD011325.pub2.
    1. Kabat-Zinn J. Wherever you go there you are: mindfulness meditation in everyday life. New York: Hyperion; 1994.
    1. Piet J, Wurtzen H, Zachariae R. The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a systematic review and meta-analysis. J Consult Clin Psychol. 2012;80(6):1007–1020. doi: 10.1037/a0028329.
    1. Zhang MF, Wen YS, Liu WY, Peng LF, Wu XD, Liu QW. Effectiveness of mindfulness-based therapy for reducing anxiety and depression in patients with cancer: a meta-analysis. Medicine. 2015;94(45):e0897. doi: 10.1097/MD.0000000000000897.
    1. van der Lee M, Garssen B. Mindfulness-based cognitive therapy reduces chronic cancer related fatigue. Psychooncology. 2013;22:102–103. doi: 10.1002/pon.3328.
    1. Johns SA, Brown LF, Beck-Coon K, Monahan PO, Tong Y, Kroenke K. Randomized controlled pilot study of mindfulness-based stress reduction for persistently fatigued cancer survivors. Psychooncology. 2015;24(8):885–893. doi: 10.1002/pon.3648.
    1. Nakamura Y, Lipschitz DL, Kuhn R, Kinney AY, Donaldson GW. Investigating efficacy of two brief mind-body intervention programs for managing sleep disturbance in cancer survivors: a pilot randomized controlled trial. J Cancer Surviv. 2013;7(2):165–182. doi: 10.1007/s11764-012-0252-8.
    1. Chiesa A, Calati R, Serretti A. Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. Clin Psychol Rev. 2011;31(3):449–464. doi: 10.1016/j.cpr.2010.11.003.
    1. Mrazek MD, Franklin MS, Phillips DT, Baird B, Schooler JW. Mindfulness training improves working memory capacity and GRE performance while reducing mind wandering. Psychol Sci. 2013;24(5):776–781. doi: 10.1177/0956797612459659.
    1. Quach D, Mano KEJ, Alexander K. A randomized controlled trial examining the effect of mindfulness meditation on working memory capacity in adolescents. J Adolesc Health. 2016;58(5):489–496. doi: 10.1016/j.jadohealth.2015.09.024.
    1. Moynihan JA, Chapman BP, Klorman R, Krasner MS, Duberstein PR, Brown KW, et al. Mindfulness-based stress reduction for older adults: effects on executive function, frontal alpha asymmetry and immune function. Neuropsychobiology. 2013;68(1):34–43. doi: 10.1159/000350949.
    1. Laneri D, Schuster V, Dietsche B, Jansen A, Ott U, Sommer J. Effects of long-term mindfulness meditation on brain’s white matter microstructure and its aging. Front Aging Neurosci. 2016;7:254. doi: 10.3389/fnagi.2015.00254.
    1. Tang Y-Y, Hoelzel BK, Posner MI. The neuroscience of mindfulness meditation. Nat Rev Neurosci. 2015;16(4):213–U80. doi: 10.1038/nrn3916.
    1. Black DS, Slavich GM. Mindfulness meditation and the immune system: a systematic review of randomized controlled trials. Ann N Y Acad Sci. 2016;1373(1):13–24. doi: 10.1111/nyas.12998.
    1. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18(6):643. doi: 10.1037/h0054651.
    1. Van der Gucht K, Smeets A, Raes F, Kuppens P, Sunaert S, Deprez S, editors. Impact of a mindfulness-based intervention on chemotherapy-induced cognitive dysfunction and brain alterations: a pilot study. Amsterdam: International Conference on Mindfulness; 2018.
    1. Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–207. doi: 10.7326/0003-4819-158-3-201302050-00583.
    1. Ponds R, Van Boxtel M, Jolles J. De Cognitive Failure Questionnaire als maat voor subjectief cognitief functioneren. Tijdschr Neuropsychol. 2006;2:37–45.
    1. Zagoraiou M. Choosing a covariate-adaptive randomization procedure in practice. J Biopharm Stat. 2017;27(5):845–57.
    1. Kabat-Zinn J. Full catastrophe living: how to cope with stress, pain and illness using mindfulness meditation. New York: Delacorte; 1990.
    1. Bartley T. Mindfulness-based cognitive therapy for cancer. Chichester: Wiley; 2011.
    1. Crane R, Eames C, Kuyken W, Hastings R, Williams J, Bartley T, et al. Development and validation of the mindfulness-based interventions – Teaching Assessment Criteria (MBI:TAC) Assessment. 2013;20(6):681–688. doi: 10.1177/1073191113490790.
    1. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–1426. doi: 10.1249/MSS.0b013e3181e0c112.
    1. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21(1):1–16. doi: 10.1111/j.2044-8260.1982.tb01421.x.
    1. Pullens MJ, De Vries J, Roukema JA. Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psychooncology. 2010;19(11):1127–1138. doi: 10.1002/pon.1673.
    1. Lovibond SH, Lovibond PF. Manual for the depression anxiety stress scales. 2. Sydney: Psychology Foundationof Australia; 1995.
    1. Foley E, Baillie A, Huxter M, Price M, Sinclair E. Mindfulness-based cognitive therapy for individuals whose lives have been affected by cancer: a randomized controlled trial. J Consult Clin Psychol. 2010;78(1):72. doi: 10.1037/a0017566.
    1. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383–392. doi: 10.1016/0022-3999(94)90099-X.
    1. Bergomi C, Tschacher W, Kupper Z. Construction and first validation of the Comprehensive Inventory of Mindfulness Experiences. Diagnostica. 2014;60(3):111–125. doi: 10.1026/0012-1924/a000109.
    1. Van der Gucht K, Dejonckheere E, Erbas Y, Takano K, Vandemoortele M, Maex E, et al. An experience sampling study examining the potential impact of a mindfulness-based intervention on emotion differentiation. Emotion. 2018;19(1):123.
    1. Bergomi C, Tschacher W, Kupper Z. Meditation practice and self-reported mindfulness: a cross-sectional investigation of meditators and non-meditators using the Comprehensive Inventory of Mindfulness Experiences (CHIME) Mindfulness. 2015;6(6):1411–1421. doi: 10.1007/s12671-015-0415-6.
    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376. doi: 10.1093/jnci/85.5.365.
    1. McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ. Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol. 2012;30(20):2500. doi: 10.1200/JCO.2011.38.5674.
    1. Dumas JA, Kutz AM, McDonald BC, Naylor MR, Pfaff AC, Saykin AJ, et al. Increased working memory-related brain activity in middle-aged women with cognitive complaints. Neurobiol Aging. 2013;34(4):1145–1147. doi: 10.1016/j.neurobiolaging.2012.08.013.
    1. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Methodol. 1995;57(1):289–300.
    1. Bauer DJ, Preacher KJ, Gil KM. Conceptualizing and testing random indirect effects and moderated mediation in multilevel models: new procedures and recommendations. Psychol Methods. 2006;11(2):142. doi: 10.1037/1082-989X.11.2.142.
    1. Lazar SW, Kerr CE, Wasserman RH, Gray JR, Greve DN, Treadway MT, et al. Meditation experience is associated with increased cortical thickness. Neuroreport. 2005;16(17):1893. doi: 10.1097/01.wnr.0000186598.66243.19.
    1. Brewer JA, Worhunsky PD, Gray JR, Tang Y-Y, Weber J, Kober H. Meditation experience is associated with differences in default mode network activity and connectivity. Proc Natl Acad Sci. 2011;108(50):20254–20259. doi: 10.1073/pnas.1112029108.
    1. Pagnoni G, Cekic M. Age effects on gray matter volume and attentional performance in Zen meditation. Neurobiol Aging. 2007;28(10):1623–1627. doi: 10.1016/j.neurobiolaging.2007.06.008.
    1. Johns SA, Von Ah D, Brown LF, Beck-Coon K, Talib TL, Alyea JM, et al. Randomized controlled pilot trial of mindfulness-based stress reduction for breast and colorectal cancer survivors: effects on cancer-related cognitive impairment. J Cancer Surviv. 2016;10(3):437–448. doi: 10.1007/s11764-015-0494-3.
    1. Grice KO, Vogel KA, Le V, Mitchell A, Muniz S, Vollmer MA. Adult norms for a commercially available nine hole peg test for finger dexterity. Am J Occup Ther. 2003;57(5):570–3.
    1. Ruff RM, Parker SB. Gender- and Age-Specific Changes in Motor Speed and Eye-Hand Coordination in Adults: Normative Values for the Finger Tapping and Grooved Pegboard Tests. Percept Mot Skills. 1993;76(3_suppl):1219–30. 10.2466/pms.1993.76.3c.1219.
    1. Schmand B, Bakker D, Saan R, Louman J. The Dutch Reading Test for Adults: a measure of premorbid intelligence level. Tijdschr Gerontol Geriatr. 1991;22(1):15–9.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi